The number of years a patient with hypofractionated cancer can live is mainly related to the pathological stage of the tumor, the severity of the disease and the treatment, and cannot be generalized. If a patient is diagnosed with obvious hypofractionated carcinoma, the malignancy is usually relatively high and the prognosis is worse in the case of equal staging. However, the specific estimation of survival should also consider the stage of the tumor. If the tumor is small and limited, without obvious metastasis, it is an early stage tumor, and even if it is a hypofractionated cancer, through standardized treatment, one can still expect a cure and long-term survival. Of course, the probability of such good outcome is smaller than that of highly differentiated cancer. Therefore, patients with hypofractionated cancer should visit medical oncology department for examination in time, and a reasonable treatment plan should be formulated by professional doctors. During the treatment, they should adjust their emotions and control their diet with balanced, nutritious and easy to digest, which is conducive to better disease control and recovery.